carmot glp 1 Efficacy and safety of incretin co-agonists: Transformative advances in cardiometabolic healthcare Carmot's CT-996 GLP-1 candidate supports

Work out regularly Type 2 diabetes and healthy individuals have higher GLP-1 levels after exercise

doi: 10.3389/fendo.2026.1709556 Received 23 September 2025 Revised 15 January 2026 Accepted 26 January 2026 Published 11 February 2026 Volume 17 - 2026 Edited by Abdel Halim Harrath, King Saud University, Saudi Arabia Reviewed by Aldo Ferreira-Hermosillo, Mexican Social Security Institute, Mexico Raquel Evelyn Horowitz, Montefiore Medical Center, United States Updates Copyright 2026 Wang, Chen, Wang, Song and Zhang

Domingues, R

Per drug: Immunosuppressants like top-selling Humira (adalimumab) command $77,000 per patient on average

doi: 10.2174/1389450053174596

The EC50 of GLP1 (7-36) is in the expected 2 digits pM range (25-60pM), while its metabolite shows a potency which is 4 logs lower and falls into the low M range